Dean Zikria
Interim Chief Executive Officer, Valion Bio, Inc.
Dean Zikria is the CEO of Valion Bio, Inc. (VBIO).
Dean Zikria co-invented novel therapeutics at Columbia University Medical Center for potential applications in traumatic brain injury, hemorrhagic shock and battlefield medicine. He spent seven years at Pfizer in strategy and business development roles within its $7 billion U.S. cardiovascular business, and serves as an advisor to UC Berkeley's SkyDeck accelerator.
Recent developments
AI summary of recent coverageRecent coverage has focused on Dean Zikria's appointment as interim CEO of Valion Bio as part of a leadership restructuring, with Thomas Jensen taking on the role of chair. Multiple outlets have reported on the move, noting Zikria's previous experience as a strategist at Pfizer.
Summarized from the headlines below; see each source for the full story.
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Dean Zikria, it will appear here — and tie into the news timeline.
Dean Zikria: FAQ
- Who is Dean Zikria?
- Dean Zikria is the Interim Chief Executive Officer of Valion Bio, Inc..
- What company does Dean Zikria lead?
- Dean Zikria is CEO of Valion Bio, Inc..